Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 Ansichten
• 08/09/23
0
0
Einbetten
administrator
Abonnenten
Dr. Prince, Professor, The University of Melbourne and Monash University, talks about the outcomes of the ALCANZA study in CD30-expressing CTCL
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare